ENHABIT INC (EHAB) Fundamental Analysis & Valuation

NYSE:EHAB • US29332G1022

13.61 USD
+0.01 (+0.07%)
Last: Mar 4, 2026, 02:01 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This EHAB fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

3

Overall EHAB gets a fundamental rating of 3 out of 10. We evaluated EHAB against 101 industry peers in the Health Care Providers & Services industry. There are concerns on the financial health of EHAB while its profitability can be described as average. EHAB is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. EHAB Profitability Analysis

1.1 Basic Checks

  • EHAB had positive earnings in the past year.
  • In the past year EHAB had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: EHAB reported negative net income in multiple years.
  • In the past 5 years EHAB always reported a positive cash flow from operatings.
EHAB Yearly Net Income VS EBIT VS OCF VS FCFEHAB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M -150M

1.2 Ratios

  • The Return On Assets of EHAB (-0.97%) is comparable to the rest of the industry.
  • EHAB has a Return On Equity of -2.10%. This is comparable to the rest of the industry: EHAB outperforms 51.49% of its industry peers.
  • EHAB's Return On Invested Capital of 4.51% is in line compared to the rest of the industry. EHAB outperforms 50.49% of its industry peers.
  • EHAB had an Average Return On Invested Capital over the past 3 years of 3.74%. This is significantly below the industry average of 9.13%.
  • The 3 year average ROIC (3.74%) for EHAB is below the current ROIC(4.51%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -0.97%
ROE -2.1%
ROIC 4.51%
ROA(3y)-7%
ROA(5y)-1.92%
ROE(3y)-15.77%
ROE(5y)-6.79%
ROIC(3y)3.74%
ROIC(5y)4.76%
EHAB Yearly ROA, ROE, ROICEHAB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -10 -20

1.3 Margins

  • EHAB has a Operating Margin of 5.96%. This is in the better half of the industry: EHAB outperforms 66.34% of its industry peers.
  • In the last couple of years the Operating Margin of EHAB has declined.
  • With a decent Gross Margin value of 48.98%, EHAB is doing good in the industry, outperforming 74.26% of the companies in the same industry.
  • In the last couple of years the Gross Margin of EHAB has remained more or less at the same level.
Industry RankSector Rank
OM 5.96%
PM (TTM) N/A
GM 48.98%
OM growth 3Y-29.61%
OM growth 5Y-4.28%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.12%
GM growth 5Y-1.19%
EHAB Yearly Profit, Operating, Gross MarginsEHAB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. EHAB Health Analysis

2.1 Basic Checks

  • EHAB has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for EHAB has been increased compared to 1 year ago.
  • Compared to 1 year ago, EHAB has a worse debt to assets ratio.
EHAB Yearly Shares OutstandingEHAB Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
EHAB Yearly Total Debt VS Total AssetsEHAB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

  • An Altman-Z score of 1.87 indicates that EHAB is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • EHAB has a Altman-Z score of 1.87. This is comparable to the rest of the industry: EHAB outperforms 46.53% of its industry peers.
  • The Debt to FCF ratio of EHAB is 8.01, which is on the high side as it means it would take EHAB, 8.01 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of EHAB (8.01) is comparable to the rest of the industry.
  • A Debt/Equity ratio of 0.78 indicates that EHAB is somewhat dependend on debt financing.
  • EHAB's Debt to Equity ratio of 0.78 is in line compared to the rest of the industry. EHAB outperforms 49.51% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF 8.01
Altman-Z 1.87
ROIC/WACC0.52
WACC8.69%
EHAB Yearly LT Debt VS Equity VS FCFEHAB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 500M 1B

2.3 Liquidity

  • EHAB has a Current Ratio of 1.58. This is a normal value and indicates that EHAB is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of EHAB (1.58) is better than 61.39% of its industry peers.
  • A Quick Ratio of 1.58 indicates that EHAB should not have too much problems paying its short term obligations.
  • The Quick ratio of EHAB (1.58) is better than 65.35% of its industry peers.
Industry RankSector Rank
Current Ratio 1.58
Quick Ratio 1.58
EHAB Yearly Current Assets VS Current LiabilitesEHAB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. EHAB Growth Analysis

3.1 Past

  • EHAB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 91.30%, which is quite impressive.
  • Looking at the last year, EHAB shows a small growth in Revenue. The Revenue has grown by 1.02% in the last year.
  • The Revenue has been decreasing by -1.07% on average over the past years.
EPS 1Y (TTM)91.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%466.67%
Revenue 1Y (TTM)1.02%
Revenue growth 3Y-2.21%
Revenue growth 5Y-1.07%
Sales Q2Q%3.94%

3.2 Future

  • Based on estimates for the next years, EHAB will show a small growth in Earnings Per Share. The EPS will grow by 7.82% on average per year.
  • The Revenue is expected to grow by 5.22% on average over the next years.
EPS Next Y170.06%
EPS Next 2Y71.42%
EPS Next 3Y45.79%
EPS Next 5Y7.82%
Revenue Next Year2.37%
Revenue Next 2Y3.26%
Revenue Next 3Y3.62%
Revenue Next 5Y5.22%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
EHAB Yearly Revenue VS EstimatesEHAB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 200M 400M 600M 800M 1B
EHAB Yearly EPS VS EstimatesEHAB Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 0.5 1

More info and screens

Find the best growth stocksShow best growing peers

5

4. EHAB Valuation Analysis

4.1 Price/Earnings Ratio

  • EHAB is valuated quite expensively with a Price/Earnings ratio of 30.93.
  • EHAB's Price/Earnings ratio is in line with the industry average.
  • EHAB is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 26.83, which is the current average of the S&P500 Index.
  • Based on the Price/Forward Earnings ratio of 22.05, the valuation of EHAB can be described as rather expensive.
  • The rest of the industry has a similar Price/Forward Earnings ratio as EHAB.
  • EHAB is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 24.95, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 30.93
Fwd PE 22.05
EHAB Price Earnings VS Forward Price EarningsEHAB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, EHAB is valued a bit cheaper than 66.34% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, EHAB is valued cheaper than 81.19% of the companies in the same industry.
Industry RankSector Rank
P/FCF 11.9
EV/EBITDA 12.46
EHAB Per share dataEHAB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15 20

4.3 Compensation for Growth

  • EHAB's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • EHAB's earnings are expected to grow with 45.79% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.18
PEG (5Y)N/A
EPS Next 2Y71.42%
EPS Next 3Y45.79%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. EHAB Dividend Analysis

5.1 Amount

  • No dividends for EHAB!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

EHAB Fundamentals: All Metrics, Ratios and Statistics

ENHABIT INC

NYSE:EHAB (3/4/2026, 2:01:03 PM)

13.61

+0.01 (+0.07%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-05
Earnings (Next)03-04
Inst Owners104.3%
Inst Owner ChangeN/A
Ins Owners2.33%
Ins Owner Change0.98%
Market Cap688.80M
Revenue(TTM)1.05B
Net Income(TTM)-11.90M
Analysts81.67
Price Target12.21 (-10.29%)
Short Float %3.2%
Short Ratio1.44
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)31.12%
Min EPS beat(2)23.34%
Max EPS beat(2)38.89%
EPS beat(4)3
Avg EPS beat(4)21.77%
Min EPS beat(4)-28.32%
Max EPS beat(4)53.19%
EPS beat(8)6
Avg EPS beat(8)34.93%
EPS beat(12)7
Avg EPS beat(12)12.51%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.11%
Min Revenue beat(2)-3.27%
Max Revenue beat(2)-0.95%
Revenue beat(4)0
Avg Revenue beat(4)-2.69%
Min Revenue beat(4)-4.23%
Max Revenue beat(4)-0.95%
Revenue beat(8)0
Avg Revenue beat(8)-3.24%
Revenue beat(12)0
Avg Revenue beat(12)-3.7%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)12.89%
PT rev (3m)27.64%
EPS NQ rev (1m)-7.6%
EPS NQ rev (3m)-3.95%
EPS NY rev (1m)-0.12%
EPS NY rev (3m)12.55%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.21%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.46%
Valuation
Industry RankSector Rank
PE 30.93
Fwd PE 22.05
P/S 0.66
P/FCF 11.9
P/OCF 11.06
P/B 1.22
P/tB N/A
EV/EBITDA 12.46
EPS(TTM)0.44
EY3.23%
EPS(NY)0.62
Fwd EY4.53%
FCF(TTM)1.14
FCFY8.41%
OCF(TTM)1.23
OCFY9.04%
SpS20.7
BVpS11.2
TBVpS-7.48
PEG (NY)0.18
PEG (5Y)N/A
Graham Number10.53
Profitability
Industry RankSector Rank
ROA -0.97%
ROE -2.1%
ROCE 5.71%
ROIC 4.51%
ROICexc 4.76%
ROICexgc 54.35%
OM 5.96%
PM (TTM) N/A
GM 48.98%
FCFM 5.53%
ROA(3y)-7%
ROA(5y)-1.92%
ROE(3y)-15.77%
ROE(5y)-6.79%
ROIC(3y)3.74%
ROIC(5y)4.76%
ROICexc(3y)3.81%
ROICexc(5y)4.84%
ROICexgc(3y)39.56%
ROICexgc(5y)58.49%
ROCE(3y)4.73%
ROCE(5y)6.02%
ROICexgc growth 3Y-27.94%
ROICexgc growth 5YN/A
ROICexc growth 3Y-21.68%
ROICexc growth 5YN/A
OM growth 3Y-29.61%
OM growth 5Y-4.28%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.12%
GM growth 5Y-1.19%
F-Score7
Asset Turnover0.85
Health
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF 8.01
Debt/EBITDA 5.02
Cap/Depr 17.25%
Cap/Sales 0.42%
Interest Coverage 1.77
Cash Conversion 70.88%
Profit Quality N/A
Current Ratio 1.58
Quick Ratio 1.58
Altman-Z 1.87
F-Score7
WACC8.69%
ROIC/WACC0.52
Cap/Depr(3y)51.64%
Cap/Depr(5y)35.82%
Cap/Sales(3y)1.58%
Cap/Sales(5y)1.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)91.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%466.67%
EPS Next Y170.06%
EPS Next 2Y71.42%
EPS Next 3Y45.79%
EPS Next 5Y7.82%
Revenue 1Y (TTM)1.02%
Revenue growth 3Y-2.21%
Revenue growth 5Y-1.07%
Sales Q2Q%3.94%
Revenue Next Year2.37%
Revenue Next 2Y3.26%
Revenue Next 3Y3.62%
Revenue Next 5Y5.22%
EBIT growth 1Y60.82%
EBIT growth 3Y-31.17%
EBIT growth 5Y-5.31%
EBIT Next Year79.42%
EBIT Next 3Y24.05%
EBIT Next 5YN/A
FCF growth 1Y632.91%
FCF growth 3Y-26.15%
FCF growth 5Y0%
OCF growth 1Y25.6%
OCF growth 3Y-25.39%
OCF growth 5Y-2.96%

ENHABIT INC / EHAB FAQ

What is the fundamental rating for EHAB stock?

ChartMill assigns a fundamental rating of 3 / 10 to EHAB.


What is the valuation status for EHAB stock?

ChartMill assigns a valuation rating of 5 / 10 to ENHABIT INC (EHAB). This can be considered as Fairly Valued.


Can you provide the profitability details for ENHABIT INC?

ENHABIT INC (EHAB) has a profitability rating of 4 / 10.


What is the expected EPS growth for ENHABIT INC (EHAB) stock?

The Earnings per Share (EPS) of ENHABIT INC (EHAB) is expected to grow by 170.06% in the next year.